According to the paper, artificial intelligence addresses a core weakness in Parkinson’s care: reliance on subjective ...

Roche RHHBY announced that it will advance pipeline candidate prasinezumab into phase III development for early-stage Parkinson’s disease. Roche has a licensing agreement with Prothena PRTA for ...

Patient-centric trial aiming to evaluate whether bezisterim can help delay disease progression reaches enrollment milestone -- Topline Results ...

Northwestern Medicine scientists have discovered that targeting neuronal signaling controlling aberrant learning in the ...

We've already seen a pen that helps people with Parkinson's disease to write clearly, but this one is a little different. By assessing its user's hand movements as they write, it can provide an early ...

A test that can detect Parkinson's disease in the early stages of the illness has moved a step closer. Scientists have developed a way of detecting a molecule linked to the condition in samples of ...

NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...

Brett Favre shared an update on his health a year after revealing he was diagnosed with Parkinson's, saying he is in the early stages of the disease.